Zanolimumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zanolimumab" in English language version.

refsWebsite

Global rank English rank

1^st place

5,225^th place

4,062^nd place

2^nd place

4^th place

11^th place

8^th place

low place

3,257^th place

3,398^th place

ama-assn.org

Clinical trial number NCT00042406 for "Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-Alpha Blocker" at ClinicalTrials.gov
"Status of clinical trials for Zanolimumab". Archived from the original on 27 May 2013. Retrieved 6 November 2011.

Mestel DS, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C (December 2008). "Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome". Expert Opinion on Biological Therapy. 8 (12): 1929–39. doi:10.1517/14712590802528696. PMID 18990079. S2CID 58115371.

Mestel DS, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C (December 2008). "Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome". Expert Opinion on Biological Therapy. 8 (12): 1929–39. doi:10.1517/14712590802528696. PMID 18990079. S2CID 58115371.

Mestel DS, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C (December 2008). "Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome". Expert Opinion on Biological Therapy. 8 (12): 1929–39. doi:10.1517/14712590802528696. PMID 18990079. S2CID 58115371.

"TenX BioPharma". Archived from the original on April 11, 2010. Retrieved August 20, 2010.

"TenX BioPharma". Archived from the original on April 11, 2010. Retrieved August 20, 2010.
Statement On A Nonproprietary Name Adopted By The USAN Council - Zanolimumab Archived 2011-06-04 at the Wayback Machine, American Medical Association.
"Status of clinical trials for Zanolimumab". Archived from the original on 27 May 2013. Retrieved 6 November 2011.